Loading insider details...
Latest Form 4 (Oct 9, 2026): Disposition to Issuer of 15,046 BLFS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | BIOLIFE SOLUTIONS INC (BLFS) | Disposition to Issuer | 15,046 | n/a |
| Jun 12, 2026 | 908 Devices Inc. (MASS) | Exercise/Conversion | 14,083 | n/a |
| Mar 3, 2026 | REPLIGEN CORP (RGEN) | Tax Withholding | 9,897 | $1.24M |
| Feb 26, 2026 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/Award | 8,170 | n/a |
| Dec 8, 2025 | REPLIGEN CORP (RGEN) | Other (see footnotes) | 2,000 | n/a |
| Nov 14, 2025 | REPLIGEN CORP (RGEN) | Sale | 1,784 | $269.4K |
| Nov 13, 2025 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 25,000 | $846.7K |
| Sep 11, 2025 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 20,000 | $677.4K |
| Jun 13, 2025 | 908 Devices Inc. (MASS) | Exercise/Conversion | 11,364 | n/a |
| May 16, 2025 | REPLIGEN CORP (RGEN) | Sale | 2,043 | $250.6K |